Annual Report 2010/11 - Sonova

Consolidated Balance Sheets
CONSOlIDATED FINANCIAl STATEmENTS
Assets 1,000 CHF Notes 31.3.2011 31.3.2010 1)
Cash and cash equivalents 11 165,133 335,931
Other current financial assets 12 28,589 17,548
Trade receivables 13 320,581 324,455
Other receivables and prepaid expenses 14 55,595 67,059
Inventories 15 167,594 143,198
Total current assets 737,492 888,191
Property, plant and equipment 16 232,112 200,647
Intangible assets 19 1,059,062 1,019,920
Investments in associates/joint ventures 17 10,827 35,086
Other non-current financial assets 18 51,084 81,437
Employee benefit assets 29 1,759
Deferred tax assets 8 81,067 96,986
Total non-current assets 1,434,152 1,435,835
Total assets 2,171,644 2,324,026
Liabilities and equity 1,000 CHF Notes 31.3.2011 31.3.2010 1)
Short-term debts 21, 24 40,135 80,876
Trade payables 61,926 65,489
Current income tax liabilities 52,413 55,123
Other current financial liabilities 24 16,905 2,789
Other short-term liabilities 22 172,130 165,467
Short-term provisions 20 116,009 110,033
Total current liabilities 459,518 479,777
Non-current financial liabilities 23, 24 231,071 390,080
long-term provisions 20 85,202 137,717
Other long-term liabilities 25 20,854 15,347
Deferred tax liabilities 8 30,287 38,597
Total non-current liabilities 367,414 581,741
Total liabilities 826,932 1,061,518
Share capital 26 3,326 3,305
Share premium 112,691 60,649
Treasury shares 1,653 (20,812)
Retained earnings 1,221,828 1,214,328
Equity attributable to equity holders of the parent 1,339,498 1,257,470
Non-controlling interests 5,214 5,038
Equity 1,344,712 1,262,508
Total liabilities and equity 2,171,644 2,324,026
1) Restated based on finalization of the acquisition accounting of Advanced Bionics (for details refer to Note 3.7).
The Notes are an integral part of the consolidated financial statements.
93